Burkitt's lymphoma

2 trials MedDRA PT
2 Registered trials
0 Recruiting
2 Unique sponsors
1 Unique IMPs
1 Commercial trials
Drug classes (ATC)
— ATC code not specified 2
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase III: 1 Phase I: 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase III

1 trial
  • Haemato Oncology Foundation For Adults Netherlands Academic
    IMP not specified
    2023-503423-25-00 2 countries 2014 n=69
    Ended

Phase I

1 trial
  • Miltenyi Biomedicine GmbH Commercial
    AUTOLOGOUS T-CELLS TRANSDUCED WITH LENTIVIRAL VECTOR EXPRESSING A CHIMERIC ANTIGEN RECEPTOR DIRECTED AGAINST CD19
    2024-513334-38-00 1 country 2018 n=49
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Miltenyi Biomedicine GmbH Commercial 1 Phase I 0
Haemato Oncology Foundation For Adults Netherlands Academic 1 Phase III 0
← All indication landscapes